Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros

Banco de datos
País/Región como asunto
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Pediatr Emerg Care ; 31(9): 652-3, 2015 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-26335230

RESUMEN

Colchicine is an anti-inflammatory drug, which has been used for the treatment of familial Mediterranean fever for several decades with narrow therapeutic-toxicity window. Colchicine poisoning is rare but frequently a life-threatening emergency condition in pediatric practice. It may occur by excessive ingestion of colchicine tablets accidentally or intentionally. Herein, we report a suicide attempt with colchicine in a 12-year-old girl who had been followed up with the diagnosis of familial Mediterranean fever. She was admitted to our emergency department with gastrointestinal complaints and subsequently died because of the rapidly deteriorating metabolic and hemodynamic conditions.


Asunto(s)
Colchicina/envenenamiento , Fiebre Mediterránea Familiar/tratamiento farmacológico , Supresores de la Gota/envenenamiento , Acidosis/inducido químicamente , Niño , Colchicina/administración & dosificación , Resultado Fatal , Femenino , Supresores de la Gota/administración & dosificación , Humanos , Intento de Suicidio
2.
Pediatr Emerg Care ; 31(11): 748-52, 2015 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-26535496

RESUMEN

OBJECTIVES: The objectives of this study were to determine the causes, location of cardiopulmonary arrest (CPA) in children, and demographics of cardiopulmonary resuscitation (CPR) in Turkish pediatric emergency departments and pediatric intensive care units (PICUs) and to determine survival rates and morbidities for both in-hospital and out-of-hospital CPA. METHODS: This multicenter descriptive study was conducted prospectively between January 15 and July 15, 2011, at 18 centers (15 PICUs, 3 pediatric emergency departments) in Turkey. RESULTS: During the study period, 239 children had received CPR. Patients' average age was 42.4 (SD, 58.1) months. The most common cause of CPA was respiratory failure (119 patients [49.8%]). The location of CPA was the PICU in 168 (68.6%), hospital wards in 43 (18%), out-of-hospital in 24 (10%), and pediatric emergency department in 8 patients (3.3%). The CPR duration was 30.7 (SD, 23.6) minutes (range, 1-175 minutes) and return of spontaneous circulation was achieved in 107 patients (44.8%) after the first CPR. Finally, 58 patients (24.2%) were discharged from hospital; survival rates were 26% and 8% for in-hospital and out-of-hospital CPA, respectively (P = 0.001). Surviving patients' average length of hospital stay was 27.4 (SD, 39.2) days. In surviving patients, 19 (32.1%) had neurologic disability. CONCLUSION: Pediatric CPA in both the in-hospital and out-of-hospital setting has a poor outcome.


Asunto(s)
Reanimación Cardiopulmonar , Paro Cardíaco/terapia , Preescolar , Servicio de Urgencia en Hospital , Femenino , Paro Cardíaco/etiología , Paro Cardíaco/mortalidad , Humanos , Unidades de Cuidado Intensivo Pediátrico , Masculino , Paro Cardíaco Extrahospitalario/etiología , Paro Cardíaco Extrahospitalario/mortalidad , Paro Cardíaco Extrahospitalario/terapia , Estudios Prospectivos , Tasa de Supervivencia , Turquía
3.
Pediatr Emerg Care ; 29(5): 659-61, 2013 May.
Artículo en Inglés | MEDLINE | ID: mdl-23640149

RESUMEN

Valproic acid (VPA) is still an important antiepileptic drug, with the broadest spectrum used in all types of seizures and syndromes. It has serious adverse effects such as hepatotoxicity, hyperammonemic encephalopathy, coagulation disorders, and pancreatitis. The incidence of VPA-associated pancreatitis has been estimated to be 1:40,000. We present a 6-year-old boy who developed acute pancreatitis (AP) and multiple-organ failure after 3 months of VPA therapy. The patient's laboratory values showed that his kidney and hepatic function had impaired and thrombocytopenia, and coagulopathy had developed. The patient's abdominal tomography showed a suspected appearance, which was consistent with pancreatitis. Because amylase and lipase levels were found to be high, AP was considered. The patient improved after cessation of VPA treatment. Ten days later, the patient recovered both clinically and laboratorial. Consequently, the patient was discharged with cure. In conclusion, AP is a rare, severe adverse reaction to VPA treatment. If a child, who is receiving VPA, develops abdominal pain and vomits, VPA-associated pancreatitis must be considered.


Asunto(s)
Anticonvulsivantes/efectos adversos , Insuficiencia Multiorgánica/inducido químicamente , Pancreatitis/inducido químicamente , Ácido Valproico/efectos adversos , Dolor Abdominal/inducido químicamente , Enfermedad Aguda , Niño , Diagnóstico Tardío , Errores Diagnósticos , Coagulación Intravascular Diseminada/etiología , Gastritis/diagnóstico , Hematemesis/inducido químicamente , Humanos , Masculino , Insuficiencia Multiorgánica/sangre , Insuficiencia Multiorgánica/complicaciones , Pancreatitis/sangre , Pancreatitis/diagnóstico , Choque/etiología , Trombocitopenia/inducido químicamente
4.
Pediatr Emerg Care ; 22(12): 810-2, 2006 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-17198214

RESUMEN

Polyarteritis nodosa (PAN) is a necrotizing angiitis that predominantly affects small- and medium-sized arteries. Polyarteritis nodosa occurs rarely during childhood. Boys and girls seem to be equally affected, with a peak at the age of 10 years. Rarely, severe and fatal gastrointestinal involvement is seen in PAN. Here, we report a 15-year-old boy with PAN, who had gastrointestinal involvement with multiple aneurysms of the hepatic and superior mesenteric arteries. This involvement could be demonstrated with conventional angiography and gastrointestinal bleeding scintigraphy. The progression of the symptoms and the decrease in the size of the aneurysms were noted after combination treatment with cyclophosphamide and prednisolone, but there was severe bleeding from small bowel, and it was taken under control by resection of jejunum. However, the patient died because of sepsis. In conclusion, severe gastrointestinal involvement in PAN is usually fatal despite aggressive therapy, as is the case in our patient.


Asunto(s)
Aneurisma/etiología , Enfermedades Gastrointestinales/complicaciones , Arteria Hepática , Arteria Mesentérica Superior , Poliarteritis Nudosa/complicaciones , Adolescente , Aneurisma/cirugía , Resultado Fatal , Enfermedades Gastrointestinales/terapia , Humanos , Masculino , Poliarteritis Nudosa/terapia , Sepsis/tratamiento farmacológico , Sepsis/microbiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA